CN113262189A

CN113262189A - Tightening and wrinkle-reducing eye cream

Info

Publication number: CN113262189A
Application number: CN202110573788.5A
Authority: CN
Inventors: 刘飞燕
Original assignee: Guangdong Meiji Technology Co Ltd
Current assignee: Guangdong Meiji Technology Co Ltd
Priority date: 2021-05-25
Filing date: 2021-05-25
Publication date: 2021-08-17

Abstract

The invention discloses a tightening and wrinkle-reducing eye cream, which belongs to the technical field of skin care products and comprises a phase A, a phase B, a phase C, a phase D and deionized water; wherein the phase A comprises the following substances: cyclopolydimethylsiloxane, pentaerythritol tetra (ethyl hexanoate), herba Boschniakiae Rossicae extract, radix Phytolaccae extract, glycosphingolipids, and plant extract; phase B comprises the following substances: eupenicillium crustaceum extract, white willow bark extract, silymarin and conditioner; phase C comprises the following substances: arginine/lysine polypeptide, hydrogenated coconut oil glyceride, vegetable oil and humectant; phase D comprises the following substances: dipotassium glycyrrhizinate, dipropylene glycol, tocopherol acetate and an emulsifier. The eye cream disclosed by the invention has excellent effects of tightening skin and fading lines, and is mild in effect and free of stimulation.

Description

Tightening and wrinkle-reducing eye cream

Technical Field

The invention relates to the technical field of skin care products, and particularly belongs to tightening and wrinkle-lightening eye cream.

Background

With the aging of the skin, the skin is continuously aged, wrinkles are more and more, particularly, eye muscles are more active, the wrinkles appear earlier and are more obvious, and eyes are the heads of facial features and have important influence on the appearance of the face, so that many women pay special attention to eye care, eye protection products with full of line in the market are endless, but the effect is difficult to satisfy consumers, and particularly, the effect on tightening eye skin and fading lines is not obvious.

Through modern scientific research, the main reason for wrinkle generation is human free radicals, meanwhile, skin moisture is lost more and more rapidly along with the increase of age, collagen, elastin and the like are gradually lost, so that the supporting effect of the skin is reduced, different collapse and damage of the human skin are caused, so that the wrinkles are formed, particularly, eye muscles are used most frequently, fatigue and moisture loss are more easily caused, and eye lines with different depths are most easily generated. Therefore, it is necessary to develop a truly effective eye cream to maintain the tightness and elasticity of the eye skin, to lighten the wrinkles of the eyes, and to improve the quality and beauty of the eye skin.

However, the eye skin is the most sensitive, so that the eye cream can have good tightening and wrinkle-lightening effects, and excessive nutrition anti-aging substances are added, so that the nutrition is excessive, fat particles are caused, and even the eye skin can be sensitive.

However, the existing components can not play a good role in tightening and weakening the wrinkles, are easy to be allergic, and are added with rare herbs to efficiently and quickly play a role in weakening the wrinkles, and are easy to cause fat grains or stimulation, for example, ginsenoside has good effects of eliminating free radicals and resisting aging, but the addition amount is too small, the effect is not obvious and the effect is not good, and more ginsenoside is added into eye cream to enhance the effect, although the effects of eliminating free radicals and resisting aging can be well achieved, the surplus nutrition can be easily caused, the fat grains are easy to appear on eyes, even the situation of allergy occurs, and the ginsenoside is fussy and difficult to extract, the purification is more difficult, the yield is very low, and the manufacturing cost is high.

Therefore, how to develop eye cream with proper nutrition, high efficiency in improving skin quality, tightening and lightening wrinkles and reducing manufacturing cost as far as possible becomes a technical problem in the field.

Disclosure of Invention

Aiming at the defects and shortcomings in the background technology, the invention provides the tightening and wrinkle-lightening eye cream which has excellent effects of tightening skin and lightening lines, and is mild in effect and free of stimulation.

In order to realize the purpose, the invention adopts the following technical scheme to realize the purpose:

a firming and wrinkle-reducing eye cream comprises a phase A, a phase B, a phase C, a phase D and deionized water;

wherein the phase A comprises the following substances: cyclopolydimethylsiloxane, pentaerythritol tetra (ethyl hexanoate), herba Boschniakiae Rossicae extract, radix Phytolaccae extract, glycosphingolipids, and plant extract;

phase B comprises the following substances: eupenicillium crustaceum extract, white willow bark extract, silymarin and conditioner;

phase C comprises the following substances: arginine/lysine polypeptide, hydrogenated coconut oil glyceride, vegetable oil and humectant;

phase D comprises the following substances: dipotassium glycyrrhizinate, dipropylene glycol, tocopherol acetate and an emulsifier.

Further measures taken are: the phase A comprises the following substances in percentage by weight: 0.2 to 0.6 percent of cyclomethicone, 0.2 to 0.6 percent of pentaerythritol tetra (ethyl hexanoate), 0.5 to 2.0 percent of eupenicillium crustaceum extract, 0.2 to 0.6 percent of pokeberry root extract, 0.2 to 0.6 percent of glycosphingolipids and 8.0 to 18.0 percent of plant extract;

the phase B comprises the following substances in percentage by weight: 0.5 to 1.5 percent of herba cistanche extract, 0.5 to 1.0 percent of white willow bark extract, 0.5 to 1.0 percent of silymarin and 2.0 to 6.0 percent of conditioner;

the phase C comprises the following substances in percentage by weight: arginine/lysine polypeptide 0.5-1.5%, hydrogenated coconut oil glyceride 0.5-1.0%, vegetable oil 3.0-7.0%, and humectant 6.0-12.0%;

the phase D comprises the following substances in percentage by weight: 0.2 to 0.6 percent of dipotassium glycyrrhizinate, 0.5 to 1.5 percent of dipropylene glycol, 0.5 to 1.0 percent of tocopherol acetate and 0.5 to 2.5 percent of emulsifier;

the balance being deionized water.

Further measures taken are: the plant extract comprises one or more of Ginseng radix extract, Ginseng radix Rubri extract, herba Erodii seu Geranii extract, radix Sophorae Flavescentis extract, Scutellariae radix extract, herba Houttuyniae extract, Mandarin orange pericarp extract, cornflower extract, Sargassum macrocephalum extract, Aspalatum linearis extract, and semen Phaseoli Radiati Germinatus extract.

Further measures taken are: the Geranium tenuipilum extract, the Scutellaria baicalensis root extract, the houttuynia cordata extract and the citrus peel extract are extracted, dissolved and stored by adopting a mixture of water and butanediol.

Further measures taken are: the plant extract comprises one or more of scutellaria baicalensis extract, honeysuckle flower extract, dictamnus dasycarpus root bark extract, glabrous greenbrier rhizome extract, fructus cnidii extract, liquorice extract, amur corktree bark extract, mint leaf extract, geranium extract, golden chamomile extract, radix sophorae flavescentis extract, purslane extract and aloe barbadensis extract;

the plant extract also comprises one or more of collard extract, herba Equiseti Arvinsis extract, caulis Hederae sinensis extract, flos Matricariae Chamomillae extract, rhizoma Ligustici Chuanxiong root powder, Notoginseng radix root extract, folium Bambusae extract, Notopterygii rhizoma extract, pericarpium Zanthoxyli extract, radix Angelicae sinensis extract, stigma croci Sativi extract, and herba Leonuri powder.

Further measures taken are: the honeysuckle flower extract, the dictamnus dasycarpus root bark extract, the glabrous greenbrier rhizome extract, the common cnidium fruit extract, the liquorice root extract and the amur corktree bark extract are extracted, dissolved and stored by adopting phenoxyethanol.

Further measures taken are: the rhizoma Ligustici Chuanxiong root powder, Notoginseng radix root extract, folium Bambusae extract, Notopterygii rhizoma extract, pericarpium Zanthoxyli extract, radix Angelicae sinensis extract, stigma croci Sativi extract, and herba Leonuri powder are extracted with p-hydroxyacetophenone and 1, 2-hexanediol, and are dissolved and stored with water and propylene glycol.

Further measures taken are: the vegetable oil comprises one or more of castor oil, sunflower oil, sweet almond oil and shea butter.

Further measures taken are: the humectant comprises one or more of 1, 2-hexanediol, triethanolamine glycerol, sorbitol, folium Menthae extract, and butanediol;

the conditioning agent comprises one or more of beta-glucan, squalane, glycerol tri (ethyl hexanoate).

Further measures taken are: the emulsifier comprises one or more of isononyl isononanoate, polydimethylsiloxane, PEG-100 stearate, cetearyl alcohol, cetearyl glucoside, hydrogenated lecithin and sorbitan stearate;

the phase also comprises a chelating agent, wherein the chelating agent comprises one or more of acryloyl dimethyl taurate/VP copolymer, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, polyquaternium-51 and EDTA disodium.

Scientific research shows that the cistanche salsa extract has the functions of resisting inflammation, resisting oxidation, resisting fatigue and aging, promoting memory and enhancing immunity, but the research is not deep, the cistanche salsa extract is never applied to skin care products, a common addition mode does not have an obvious effect in the skin care products, the effect of resisting wrinkles and tightening the skin is not found, and the problem of stimulation or allergy is caused by improper addition.

However, long-term research and experiments show that the cistanche deserticola extract is added, and then a small amount of the extract is added, so that the cistanche deserticola extract can play an outstanding skin firming and tendering effect, does not generate irritation, and can be used for balancing and protecting the skin mildly. The cistanche salsa extract is used for enhancing SOD activity, promoting superoxide anion free radicals to be changed into hydrogen peroxide and oxygen ions, further reducing lipid peroxidation, protecting cells and tissues of an organism from damage, simultaneously reducing MDA content and inhibiting MAO activity, reducing SDH activity, enhancing LDH activity, effectively improving energy metabolism of cells, balancing performances of the cistanche salsa extract through the pokeberry extract, interacting, enhancing immunity of skin, promoting nutrient absorption of skin, avoiding overnutrition, eliminating adverse reactions, enabling cells to be rich in activity and in an optimal active state, recovering water retention and barrier effects of skin, improving elasticity and compactness of skin, and further lightening canthus lines. Moreover, the cistanche deserticola is relatively easy to obtain, the extraction rate is high, the extraction process is simple and convenient, so that expensive specific substances such as ginsenoside and the like can be avoided, the manufacturing cost is reduced, the efficacy is outstanding, the anti-aging and firming effects are better, and the better effect can be exerted in eye cream

In addition, in order to further improve the effects of wrinkle reduction and wrinkle resistance, eupenicillium crusta extract, white willow bark extract, silymarin, arginine/lysine polypeptide, hydrogenated coconut oil glyceride, dipotassium glycyrrhizinate and tocopheryl acetate are added, and particularly, excellent effects of skin smoothing, wrinkle reduction and wrinkle resistance are obtained by adding the penicillium extract, the white willow bark extract and the silymarin, reasonably matching and mutually cooperating. The penicillium incarnatum extract is beneficial to smoothing fine lines of the skin and relieving the skin edema, but is easy to generate irritation when being added, so that the skin absorption is influenced, the white willow bark extract plays a good anti-aging role, simultaneously, the irritation factor of the penicillium incarnatum extract is inhibited, a mild stress response is initiated, the silymarin can maintain the balance of an oxidation-reduction system in cells, the loss of antioxidants such as glutathione in vivo is reduced, and the skin oxidation stress response induced by ultraviolet light can be inhibited, so that the skin aging is delayed, the penicillium extract, the white willow bark extract and the silymarin interact with one another, so that the wrinkles of eyes can be obviously faded and repaired, the fine lines are prevented from being generated, and the skin of the eyes is smoother and smoother. Arginine/lysine polypeptide, hydrogenated coconut oil glyceride, dipotassium glycyrrhizinate, tocopherol acetate and a conditioner are introduced to condition the skin of the skin, and the water-oil balance and the vitality of the skin are kept, so that the skin is acted together with various substances, the overall quality of the skin is improved, the smoothness and the fineness of the eye skin are really and effectively improved, the skin is revived and the skin is more youthful.

The invention also reduces the loss of beneficial factors in the extraction process of each plant by specially processing the extraction of each plant extract, carefully selects the extraction solvent, reduces the irritation, greatly improves the extraction rate, saves the production cost, simultaneously more effectively exerts the efficacy of each substance, and finally matches with a simple and proper preparation method, thereby preparing the eye cream with high quality and outstanding efficacy.

Through the technical scheme, compared with the prior art, the invention has the following beneficial effects:

1. the eye cream has the advantages that the herba cistanche extract and a small amount of radix cynanchi wilfordii are added, so that the effects of tightening and tendering the skin are outstanding, irritation is not generated, the skin is balanced and mild, the skin is tightened and elastic, the herba cistanche is easy to obtain, the extraction process is simple and convenient, the use of expensive special-effect substances can be avoided, the manufacturing cost is reduced, the effect is outstanding, and the eye cream can play a better effect.

2. The invention also achieves excellent effects of smoothing skin, lightening lines and resisting wrinkles by adding substances such as eupenicillium crustaceum extract, white willow bark extract, silymarin, arginine/lysine polypeptide and the like and cooperating with each other, and the quality of the whole skin is improved by reasonably matching the substances.

2. The invention also adopts special solvent to extract different plants, so that the loss of beneficial factors can be reduced in the extraction process of each plant, the extraction rate is greatly improved, the production cost is saved, and the efficacy of each substance is more effectively exerted.

Detailed Description

In order to clearly understand the technical solutions adopted by the present invention, the following description is made on the preferred embodiments of the present invention, and it should be understood that the embodiments described herein are only used for illustrating and explaining the present invention, and are not used to limit the present invention.

Examples 1 to 4: the specific components and the corresponding weight percentages of the firming and wrinkle-reducing eye cream are shown in the following table 1.

Table 1: example ingredients and proportions

Wherein: the plant extract comprises one or more of Ginseng radix extract, Ginseng radix Rubri extract, herba Erodii seu Geranii extract, radix Sophorae Flavescentis extract, Scutellariae radix extract, herba Houttuyniae extract, Mandarin orange pericarp extract, cornflower extract, Sargassum macrocephalum extract, Aspalatum linearis extract, and semen Phaseoli Radiati Germinatus extract. The Geranium tenuipilum extract, Scutellariae radix extract, herba Houttuyniae extract, and Mandarin orange pericarp extract are extracted with mixture of water and butanediol, dissolved, and stored.

The plant extract can also be one or more of Scutellariae radix extract, flos Lonicerae extract, cortex Dictamni Radicis extract, rhizoma Smilacis Glabrae extract, fructus Cnidii extract, Glycyrrhrizae radix extract, cortex Phellodendri extract, folium Menthae extract, Pelargonium graveolens extract, flos Chrysanthemi Indici extract, radix Sophorae Flavescentis extract, herba Portulacae extract, and Aloe Barbadensis extract; the plant extract also comprises one or more of herba Alternantherae sessilis extract, herba Equiseti Arvinsis extract, caulis Hederae sinensis extract, flos Matricariae Chamomillae extract, rhizoma Ligustici Chuanxiong root powder, Notoginseng radix root extract, folium Bambusae extract, Notopterygii rhizoma extract, pericarpium Zanthoxyli extract, radix Angelicae sinensis extract, flos Carthami extract, and herba Leonuri powder.

Extracting the above flos Lonicerae extract, cortex Dictamni Radicis extract, rhizoma Smilacis Glabrae extract, fructus Cnidii extract, Glycyrrhrizae radix extract, and cortex Phellodendri extract with phenoxyethanol, dissolving, and storing.

The above rhizoma Ligustici Chuanxiong root powder, Notoginseng radix root extract, folium Bambusae extract, Notopterygii rhizoma extract, pericarpium Zanthoxyli extract, radix Angelicae sinensis extract, stigma croci Sativi extract, and herba Leonuri powder are extracted with p-hydroxyacetophenone and 1, 2-hexanediol, and are dissolved and stored with water and propylene glycol.

The vegetable oil comprises one or more of castor oil, sunflower oil, sweet almond oil, and shea butter. The humectant comprises one or more of 1, 2-hexanediol, triethanolamine glycerol, sorbitol, folium Menthae extract, and butanediol; the conditioning agent comprises one or more of beta-glucan, squalane, glycerol tri (ethyl hexanoate).

The emulsifier comprises one or more of isononyl isononanoate, polydimethylsiloxane, PEG-100 stearate, cetearyl alcohol, cetearyl glucoside, hydrogenated lecithin and sorbitan stearate; the phase D also comprises a chelating agent, and the chelating agent comprises one or more of acryloyl dimethyl taurate/VP copolymer, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, polyquaternium-51 and EDTA disodium. And trace essence can be added into the phase D.

The control group 1 contained the same substances as in example 3 except that no phytolacca acinosa extract was added.

The control group 2 contained the same substances as in example 3 except that the eupenicillium crustaceum extract was not added.

The control group 3 contained the same substances as in example 3, except that the white willow bark extract was not added.

The control group 4 contained the same substances as in example 3 except that silymarin was not added.

Examples 1-4 above, as well as controls 1-4, were prepared by the following preparation method, including the steps of:

s1: adding deionized water with corresponding mass percentage into an emulsifying pot, sequentially adding A-phase substances with corresponding weight percentage into the emulsifying pot in the heating process, slowly stirring while adding, homogenizing for 2-4 minutes when the A-phase substances are completely added into the stirring pot and the heating temperature is 82-86 ℃, and then preserving heat for 20 minutes for later use;

s2: cooling the mixture obtained in the step S1 to 45 ℃, preserving the heat, sequentially adding the phase B substances with the corresponding mass percentage into the same emulsifying pot, stirring until the phase B substances are completely dissolved, then adding the phase C substances with the corresponding mass percentage, and stirring until the phase C substances are completely dissolved for later use;

s3: and (4) heating the mixture obtained in the step S2 to 50 ℃, adding a D-phase substance in a corresponding mass percentage, homogenizing for 3-5 minutes, transferring to room temperature, and slowly cooling to room temperature to obtain a finished product.

The control group 5 was a commercially available normal eye cream with tightening and wrinkle-reducing effects.

Effect test: the effect comparison test was performed on the finished products obtained in examples 1 to 4 and control groups 1 to 4 above, and the product of control group 5 purchased in the market.

The experimental control conditions and procedures were as follows:

in the same area, 90 female volunteers aged 28-45 years were selected at the same time, and each volunteer had loose skin, lack of elasticity, and moderate or mild wrinkles around the eyes, but no other obvious skin diseases. Then, the volunteers were divided into 9 groups at random, 10 volunteers in each group, and 9 groups of volunteers were treated with the products of examples 1 to 4 and control groups 1 to 5, respectively, and after the face was cleaned every morning and evening, eye care was performed using the eye cream of the corresponding test, followed up and fed back every day, and data was recorded.

Eye skin elasticity test

The elasticity of the eye skin of each group of volunteers was measured weekly using an Elastimeter skin elasticity tester, continuously for four weeks, and the average value of each group was recorded, and the statistical results are shown in table 2 below.

Table 2: skin elasticity test results

As can be seen from table 2 above, compared with the eye cream of the control group 5 purchased in the market, the eye creams of the present embodiments 1 to 4 have excellent effects of improving skin elasticity and restoring firmness, and although the eye creams of the control groups 1 to 4 are all better than the eye creams purchased in the market and can improve skin elasticity and make skin firm and lively, the effects are not as good as those of the eye creams obtained in the embodiments 1 to 4. Therefore, although scientific research shows that the cistanche salsa extract has the effects of resisting inflammation, resisting oxidation, resisting fatigue and resisting aging, simple addition or combination cannot obviously exert the effects of improving skin elasticity and recovering skin compactness, and the cistanche salsa extract is required to be matched with the pokeberry root extract to stimulate the excellent performance; the eupenicillium crustaceum extract, the white willow bark extract and the silymarin also have the promotion effects of improving the elasticity of skin and restoring the firmness and vitality.

(II) Ocular skin wrinkle reduction test

The wrinkle depth around the eyes of each group of volunteers was measured using an eye wrinkle meter every month for 3 months, and then the decrease in wrinkle depth compared to that of the volunteers before use was recorded, and the average value of each group was calculated, and then summarized and counted, and the results are shown in table 3 below.

Table 2: test results of skin wrinkle reduction test

As is apparent from table 3 above, the eye creams of examples 1 to 4 have excellent wrinkle-reducing anti-wrinkle effects, particularly the eye cream obtained in example 3 has significant wrinkle-reducing anti-wrinkle effects, compared to the eye cream of control 5 purchased on the market. Although the eye creams of the control groups 1 to 4 have better wrinkle-reducing effects than the eye creams purchased on the market, the effects are not as good as those of the eye creams obtained in the examples 1 to 4, especially the eye creams obtained in the control groups 2 to 4 are far from those of the eye cream obtained in the example 3, so that the penicillium crustaceum extract, the willow bark extract and the silymarin have quite important effects on wrinkle-reducing and wrinkle-resisting effects, and the three components supplement each other and are not enough, and the remarkable wrinkle-reducing and wrinkle-resisting effects can be exerted only through organic combination of the three components, so that the smooth and flat skin is restored. Of these, example 3 is the most preferred example of this experiment.

(III) eye irritation test

The feedback condition of each group of volunteers on the use of each test product is collected, the skin of each volunteer is inspected, comprehensive evaluation is carried out, the volunteers with allergic conditions in each group are recorded, the number of the volunteers with allergic conditions in each group is counted in 2 weeks and 4 weeks, and the results are summarized as shown in the following table 4.

Table 2: skin irritation test results

Test products	After 2 weeks of use	After 4 weeks of use
			Example 1	0	0
Example 2	0	0
			Example 3	0	0
Example 4	0	0
			Control group 1	1	2
Control group 2	0	1
			Control group 3	0	0
Control group 4	0	0
			Control group 5	2	4

As can be seen from the statistical results in table 4 above, the eye creams obtained in the embodiments 1 to 4 are mild and non-irritant, and are suitable for long-term use, the eye creams of the comparison group 5 purchased in the market have a certain wrinkle-reducing effect, but have certain irritation compared with skin, and are not suitable for long-term use, especially sensitive skin, and in addition, the eye creams obtained in the comparison groups 1 and 2 also have mild allergy to volunteers, and also have mild irritation, so that the cistanche salsa extract needs to be used with the phytolacca acinosa extract to eliminate irritation and stimulate the excellent skin care effect of the cistanche salsa extract; the eupenicillium crustaceum extract needs to be matched with the white willow bark extract and the silymarin and can reduce irritation only by mutual coordination, and the wrinkle-reducing and anti-wrinkle effects can be better exerted.

In conclusion, the eye cream obtained by the embodiment of the invention has the advantages of excellent skin tightening, skin elasticity improvement and line fading, so that the effects of tightening light lines and improving the quality of eye skin are achieved, and the eye cream is mild, has no stimulation and is suitable for long-time use.

The above description is only for the purpose of illustrating the embodiments of the present invention and not for the purpose of limiting the same, and equivalent modifications and variations of the embodiments of the present invention will be apparent to those skilled in the art without departing from the overall spirit of the invention.

Claims

1. A firming and wrinkle-reducing eye cream is characterized in that: comprises a phase A, a phase B, a phase C, a phase D and deionized water;

2. The tightening and wrinkle-reducing eye cream as set forth in claim 1, wherein: the phase A comprises the following substances in percentage by weight: 0.2 to 0.6 percent of cyclomethicone, 0.2 to 0.6 percent of pentaerythritol tetra (ethyl hexanoate), 0.5 to 2.0 percent of eupenicillium crustaceum extract, 0.2 to 0.6 percent of pokeberry root extract, 0.2 to 0.6 percent of glycosphingolipids and 8.0 to 18.0 percent of plant extract;

the balance being deionized water.

3. The tightening and wrinkle-reducing eye cream as set forth in claim 1, wherein: the plant extract comprises one or more of Ginseng radix extract, Ginseng radix Rubri extract, herba Erodii seu Geranii extract, radix Sophorae Flavescentis extract, Scutellariae radix extract, herba Houttuyniae extract, Mandarin orange pericarp extract, cornflower extract, Sargassum macrocephalum extract, Aspalatum linearis extract, and semen Phaseoli Radiati Germinatus extract.

4. The tightening and wrinkle-reducing eye cream as set forth in claim 3, wherein: the Geranium tenuipilum extract, the Scutellaria baicalensis root extract, the houttuynia cordata extract and the citrus peel extract are extracted, dissolved and stored by adopting a mixture of water and butanediol.

5. The tightening and wrinkle-reducing eye cream as set forth in claim 1, wherein: the plant extract comprises one or more of scutellaria baicalensis extract, honeysuckle flower extract, dictamnus dasycarpus root bark extract, glabrous greenbrier rhizome extract, fructus cnidii extract, liquorice extract, amur corktree bark extract, mint leaf extract, geranium extract, golden chamomile extract, radix sophorae flavescentis extract, purslane extract and aloe barbadensis extract;

6. The tightening and wrinkle-reducing eye cream as set forth in claim 5, wherein: the honeysuckle flower extract, the dictamnus dasycarpus root bark extract, the glabrous greenbrier rhizome extract, the common cnidium fruit extract, the liquorice root extract and the amur corktree bark extract are extracted, dissolved and stored by adopting phenoxyethanol.

7. The tightening and wrinkle-reducing eye cream as set forth in claim 5, wherein: the rhizoma Ligustici Chuanxiong root powder, Notoginseng radix root extract, folium Bambusae extract, Notopterygii rhizoma extract, pericarpium Zanthoxyli extract, radix Angelicae sinensis extract, stigma croci Sativi extract, and herba Leonuri powder are extracted with p-hydroxyacetophenone and 1, 2-hexanediol, and are dissolved and stored with water and propylene glycol.

8. The tightening and wrinkle-reducing eye cream as set forth in claim 1, wherein: the vegetable oil comprises one or more of castor oil, sunflower oil, sweet almond oil and shea butter.

9. The tightening and wrinkle-reducing eye cream as set forth in claim 1, wherein: the humectant comprises one or more of 1, 2-hexanediol, triethanolamine glycerol, sorbitol, folium Menthae extract, and butanediol;

10. The tightening and wrinkle-reducing eye cream as set forth in claim 1, wherein: the emulsifier comprises one or more of isononyl isononanoate, polydimethylsiloxane, PEG-100 stearate, cetearyl alcohol, cetearyl glucoside, hydrogenated lecithin and sorbitan stearate;

the phase D also comprises a chelating agent, and the chelating agent comprises one or more of acryloyl dimethyl taurate/VP copolymer, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, polyquaternium-51 and EDTA disodium.